# Anto Biosciences Landing Page Growth Score | YC F25

Lazyweb publishes a public search API over its indexed pages; the guide is at https://www.lazyweb.com/agent-access.

Source: https://www.lazyweb.com/yc-f25/anto-biosciences
Source observed: 2026-10-08T01:35:09.144Z
Last checked: 2026-10-20T07:18:38.405+00:00
Indexed: 2026-10-08T02:07:00.819+00:00

---

# Anto Biosciences landing page growth score

We evaluated [Anto Biosciences](https://www.anto.bio/) as part of YC F25. The report's overall **Growth Score is 53/100**, updated **September 23, 2026**, and identifies **CTA** as the weakest category.

## Overall ranking and category scores

Anto Biosciences ranks fifth in the displayed comparison:

1. [Cradle — 74](https://www.lazyweb.com/growth-score/site/cradle.bio)
2. [Bioptimus — 66](https://www.lazyweb.com/growth-score/site/bioptimus.com)
3. [EvolutionaryScale — 60](https://www.lazyweb.com/growth-score/site/evolutionaryscale.ai)
4. [Basecamp Research — 57](https://www.lazyweb.com/growth-score/site/basecamp-research.com)
5. Anto Biosciences — **53**

| Category | Score |
| --- | ---: |
| CTA | **42** |
| Value props | **52** |
| Trust | **55** |
| Information hierarchy | **58** |
| Mobile web | **58** |

[Fix CTA](https://www.lazyweb.com/plans/checkout?plan=individual&source=growth_score_feature_build_fixes)

## Score over time

The report lists these historical observations:

1. **September 23, 2026 — 53**, live; overall +1, CTA +4, Trust +3.
2. [June 8, 2026 — 52](https://www.lazyweb.com/growth-score/history/2026-06-08); overall −1, Trust −6.
3. [May 16, 2026 — 53](https://www.lazyweb.com/growth-score/history/2026-05-16); overall +2, Trust +6, Mobile web +2.
4. [April 16, 2026 — 51](https://www.lazyweb.com/growth-score/history/2026-04-16); first tracked report, strongest Information hierarchy 58 and weakest CTA 38.

## CTA — 42, Poor

We assess the CTA using copy, size, verb, and cost-feel: does the primary CTA earn the click?

### Problems identified

- No hero CTA button at all.
- The only action is a navigation link.
- Mobile hides links in a hamburger menu.
- Diagram pills look clickable but are not.

The CTA comparison ranks Anto Biosciences fourth:

1. Bioptimus — 68
2. Cradle — 64
3. EvolutionaryScale — 62
4. Anto Biosciences — **42**
5. Basecamp Research — 42

Our **CTA rewrite studio** is a Pro feature: [Rewrite this CTA](https://www.lazyweb.com/backlog?site=anto.bio#opt-cta-writing). It generates primary and secondary CTA options grounded in Anto Biosciences' offer and visitor objections.

## Value props — 52, Fair

We assess whether the title, subtitle, and hero sell the product's true value.

The reviewed headline is:

> “We are a frontier biology AI lab making the gut microbiome computable for the first time.”

### Working

- “Computable for the first time” is a bold, ownable claim.
- A YC badge lends instant credibility.
- The statement names the exact domain: the gut microbiome.

### Could improve

- The H1 is only the company name and sells nothing.
- No numbers, outcomes, or audience are named.
- Orbit labels are unexplained jargon.

Value-proposition ranking:

1. Cradle — 78
2. Bioptimus — 68
3. Basecamp Research — 62
4. Anto Biosciences — **52**
5. EvolutionaryScale — 48

## Trust — 55, Fair

We assess proof that the product is real, competent, and safe to try.

| Company | Trust read |
| --- | --- |
| Anto Biosciences | “Backed by Y Combinator” badge beneath the ANTO wordmark |
| Basecamp Research | No visible trust signal identified. |
| Cradle | News bar: “Lundbeck partners with Cradle to discover and optimize brain disorder treatments” |
| EvolutionaryScale | “EvolutionaryScale is joining forces with Biohub. Learn more at biohub.org” announcement bar |
| Bioptimus | “Trusted by 16 of the top 20 pharma companies \| 1,000+ institutions worldwide” |

Trust ranking:

1. Cradle — 68
2. Bioptimus — 62
3. Anto Biosciences — **55**
4. EvolutionaryScale — 48
5. Basecamp Research — 42

Our **Proof section builder** is a Pro feature: [Build proof section](https://www.lazyweb.com/backlog?site=anto.bio#opt-trust-signals). It helps choose proof signals and provides copy and placement for a stronger trust section.

## Information hierarchy — 58, Fair

We assess whether the design helps or inhibits what the page is trying to say.

![Information hierarchy annotations on the desktop capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/anto.bio.jpg?v=2026-09-23T00%3A42%3A42.272%2B00%3A00)

1. **Five equal-weight navigation links:** all five nav items share the same styling, so the “Work with us” conversion path receives no visual priority over Home or Team.
2. **Concept-node diagram:** labels such as “Sparsification” and “Tokenization” are jargon nodes occupying half the fold without explaining outcomes or inviting action.
3. **“ANTO” wordmark headline:** the largest text is the company name, which outranks the actual value proposition set in small grey type below.

Our **Layout priority plan** is a Pro feature: [View layout plan](https://www.lazyweb.com/backlog?site=anto.bio#opt-information-hierarchy). It turns these callouts into a sequenced plan to keep, move, merge, or remove content.

## Mobile web — 58, Fair

We assess the phone experience as a first-class part of the page.

![Mobile web annotations on the mobile capture](https://zlfyzdmohcskkucuunmk.supabase.co/storage/v1/object/public/sites/growth-score/site/anto.bio-mobile.jpg?v=2026-09-23T00%3A42%3A42.272%2B00%3A00)

1. **Concept diagram graphic:** the large non-interactive orb diagram consumes the fold's prime tap zone where a CTA belongs.
2. **Backed by YC badge:** the badge occupies the position where a primary button would go, providing social proof but no action.

Our **Mobile fix plan** is a Pro feature: [View mobile fixes](https://www.lazyweb.com/backlog?site=anto.bio#opt-mobile-web). It converts the mobile findings into a prioritized implementation checklist.

## Competitors

The report infers competitors from product, audience, and value proposition:

1. [Cradle — cradle.bio — 74](https://www.lazyweb.com/growth-score/site/cradle.bio)
2. [Bioptimus — bioptimus.com — 66](https://www.lazyweb.com/growth-score/site/bioptimus.com)
3. [EvolutionaryScale — evolutionaryscale.ai — 60](https://www.lazyweb.com/growth-score/site/evolutionaryscale.ai)
4. [Basecamp Research — basecamp-research.com — 57](https://www.lazyweb.com/growth-score/site/basecamp-research.com)
5. Anto Biosciences — **53**

---

[Read this page’s summary](https://www.lazyweb.com/api/public/v1/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f25%2Fanto-biosciences&trace=t_bc7e1c4e5b07)

## Ask a follow-up about this page

Need a more specific answer? Ask the exact question you have. It returns a fresh, cited answer from Lazyweb’s knowledge base. No account or API key required.

Open this URL with your own question, URL-encoded. Only q is required. No account or setup.

`GET https://www.lazyweb.com/agent/faq?q={question}&trace=t_bc7e1c4e5b07`

[Tool guide and examples](https://www.lazyweb.com/agent-access) · [OpenAPI](https://www.lazyweb.com/api/public/v1/openapi.json) · [Page TLDR form](https://www.lazyweb.com/agent-tools/page-tldr?url=https%3A%2F%2Fwww.lazyweb.com%2Fyc-f25%2Fanto-biosciences). Opening a form does not execute a tool.